If you’ve recently had a conversation with your doctor about fertility and heard the term “AMH,” you’re not alone. Anti-Müllerian hormone has become one of the most commonly discussed markers of ovarian reserve — and for many women over 35, it can feel like a number that carries enormous weight. Understanding what AMH actually measures, what the research suggests about it, and what it does and doesn’t tell you may help bring some clarity to what can otherwise feel like an overwhelming topic.
It’s worth noting from the outset that AMH is one data point among many. Research consistently shows that fertility is multifactorial, and individual hormone levels vary considerably — even among women of the same age who go on to have similar reproductive outcomes. This piece explores what current science says about AMH after 35, without drawing conclusions that belong in a conversation with your healthcare provider.
What AMH Measures — and What It Doesn’t
AMH is produced by the granulosa cells of small, developing follicles in the ovaries. Because follicle counts naturally decline with age, AMH levels tend to decrease over time as well. According to research published through the National Institutes of Health, AMH provides an estimate of ovarian reserve — essentially, a window into the quantity of remaining eggs. What it doesn’t measure with precision is egg quality, which is a separate and equally important factor in fertility.
This distinction matters. A woman with lower AMH may still have eggs of high quality, and a woman with higher AMH may face other challenges. The NIH notes that AMH is most useful when interpreted alongside other clinical information, including antral follicle counts (seen on ultrasound), FSH levels, and a complete fertility evaluation. No single marker tells the full story.
Normal Ranges and Age-Related Variation
Reference ranges for AMH shift with age, and what’s considered “normal” at 28 differs from what’s considered within range at 38. Laboratories use varying reference intervals, which is one reason the same numerical result can carry different implications depending on how and where it’s measured. Some research suggests that women over 35 may have AMH levels that, while lower than their younger counterparts, still fall within ranges associated with natural conception. Individual variation is significant.
How AMH Relates to Fertility After 35
Research on AMH as a predictor of fertility outcomes in women trying to conceive naturally (rather than through assisted reproduction) shows more nuance than popular coverage often suggests. A widely cited study found that among women under 38 with no known fertility issues, AMH did not significantly predict time to natural conception — a finding that surprised many in the reproductive medicine field.
Where AMH does appear to play a more direct role is in the context of IVF and other assisted reproductive technologies. In that setting, it helps clinicians estimate ovarian response to stimulation medications, which affects treatment planning. Women with lower AMH may respond differently to stimulation protocols, and this is one area where the hormone’s predictive value is more established. If you’re considering or currently exploring assisted reproduction, discussing your AMH in that specific context with a reproductive endocrinologist may be particularly informative.
For those trying to conceive naturally, understanding how your AMH fits within a broader fertility picture — including understanding your menstrual cycle after 35 — may offer more actionable context than a number alone.
What Changes After Age 35
The relationship between age and AMH follows a general downward trajectory, though the pace varies considerably. Research suggests that AMH declines more steeply for some women than for others, and that genetic factors, lifestyle elements, and health history may all play a role in this variation. Some women in their late 30s maintain AMH levels that overlap with ranges more commonly seen in younger age groups; others experience earlier or steeper declines.
Factors That May Influence AMH Levels
Several factors have been studied in relation to AMH variation beyond age. Research has explored associations with body mass index, smoking history, vitamin D status, and certain health conditions including polycystic ovary syndrome (which is often associated with elevated AMH). Autoimmune conditions and prior ovarian surgeries may also be relevant. None of these associations is absolute, and the clinical significance varies by individual. If you have questions about factors that might be relevant to your specific AMH result, a reproductive endocrinologist or your OB/GYN is best positioned to help interpret your situation.
Getting Tested and Interpreting Results
AMH can be measured at any point in the menstrual cycle, which makes it a convenient test compared to some other fertility markers. Blood is drawn and sent to a laboratory, and results are typically returned within a few days. Many OB/GYNs, fertility specialists, and even some primary care physicians can order this test.
When results come back, context matters enormously. A result that appears low in a generic online chart may fall within an age-appropriate range when interpreted by a clinician familiar with laboratory-specific reference ranges and your broader health picture. Conversely, a result that appears “normal” doesn’t guarantee fertility without additional evaluation. Working with a knowledgeable provider to understand what your number means for you — not for a hypothetical average — is the most useful approach.
Frequently Asked Questions
Can AMH levels change over time?
Research generally shows AMH as a declining marker over time rather than one that fluctuates significantly month to month. However, some studies have documented modest variation, and certain factors (such as vitamin D supplementation in women who are deficient) have been associated with small changes in some individuals. If you’re retesting, discussing the timing and interpretation with your provider helps ensure the most meaningful comparison.
Does a low AMH mean I can’t get pregnant?
A low AMH does not mean conception is impossible. Many women with lower-than-average AMH for their age have conceived naturally or with assistance. AMH reflects egg quantity estimates, not quality, and does not account for the many other factors involved in conception and pregnancy. A reproductive endocrinologist can provide the most complete picture of your individual fertility landscape.
Should I get my AMH tested if I’m over 35 and not yet trying to conceive?
This is a personal decision best made in conversation with your healthcare provider. Some women find that knowing their AMH helps them plan and prepare emotionally; others find it creates unnecessary anxiety given the significant limitations in what the number can predict. Your provider can help you weigh the potential benefits and limitations of testing given your specific circumstances and goals.
Is AMH testing covered by insurance?
Coverage varies by insurance plan, provider, and clinical indication. Some insurers cover AMH as part of infertility evaluation; others do not cover it for preconception planning without a qualifying diagnosis. Checking with your insurance provider before testing helps avoid unexpected costs.
Key Takeaways
- AMH measures an estimate of ovarian reserve (egg quantity), but does not directly assess egg quality — both are relevant to fertility outcomes.
- Research suggests AMH is a stronger predictor of ovarian response in assisted reproduction than of natural conception outcomes, particularly for women under 38.
- Age-related AMH decline varies considerably among individuals; reference ranges differ by laboratory and should be interpreted by a clinician familiar with your full health context.
- A low AMH result does not rule out natural conception; it is one data point in a multifactorial picture.
- Consulting a reproductive endocrinologist or your OB/GYN is the most reliable way to understand what your AMH level means for your specific fertility situation.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.